Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Primary docetaxel chemotherapy in patients with breast cancer impacted survival
June 2nd, 2005
Researchers claimed positive results with docetaxel chemotherapy in patients with breast cancer. "Primary chemotherapy achieves high clinical response rates and facilitates breast conservation in many patients with large and locally advanced breast cancer. It may also serve to indicate responsiveness to chemotherapeutic agents. A pathological complete response to primary chemotherapy is a primary predictor and surrogate marker of long-term outcome, but occurs in only approximately 15% of patients," scientists writing in the journal Breast Cancer Research and Treatment reported. "Docetaxel is of particular interest in this setting. Primary...
Source: Women's Health Weekly (2005-06-02)
|
